Your browser doesn't support javascript.
loading
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Zeng, Peter Y F; Prokopec, Stephenie D; Lai, Stephen Y; Pinto, Nicole; Chan-Seng-Yue, Michelle A; Clifton-Bligh, Roderick; Williams, Michelle D; Howlett, Christopher J; Plantinga, Paul; Cecchini, Matthew J; Lam, Alfred K; Siddiqui, Iram; Wang, Jianxin; Sun, Ren X; Watson, John D; Korah, Reju; Carling, Tobias; Agrawal, Nishant; Cipriani, Nicole; Ball, Douglas; Nelkin, Barry; Rooper, Lisa M; Bishop, Justin A; Garnis, Cathie; Berean, Ken; Nicolson, Norman G; Weinberger, Paul; Henderson, Ying C; Lalansingh, Christopher M; Tian, Mao; Yamaguchi, Takafumi N; Livingstone, Julie; Salcedo, Adriana; Patel, Krupal; Vizeacoumar, Frederick; Datti, Alessandro; Xi, Liu; Nikiforov, Yuri E; Smallridge, Robert; Copland, John A; Marlow, Laura A; Hyrcza, Martin D; Delbridge, Leigh; Sidhu, Stan; Sywak, Mark; Robinson, Bruce; Fung, Kevin; Ghasemi, Farhad; Kwan, Keith; MacNeil, S Danielle.
Afiliação
  • Zeng PYF; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada; London Regional Cancer Program, London, ON, Canada; Lawson Health Research Institute, London, ON, Canada; Department of Oncology, Western University, London, ON, Canada.
  • Prokopec SD; Ontario Institute for Cancer Research, Toronto, ON, Canada; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Lai SY; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pinto N; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada.
  • Chan-Seng-Yue MA; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Clifton-Bligh R; Division of Endocrinology, Royal North Shore Hospital, and University of Sydney, Sydney, NSW, Australia.
  • Williams MD; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Howlett CJ; Department of Pathology, Western University, London, ON, Canada.
  • Plantinga P; Department of Pathology, Western University, London, ON, Canada.
  • Cecchini MJ; Department of Pathology, School of Medicine, Griffith University, Gold Coast, QLD, Australia.
  • Lam AK; Department of Pathology, School of Medicine, Griffith University, Gold Coast, QLD, Australia.
  • Siddiqui I; Department of Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
  • Wang J; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Sun RX; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Watson JD; Ontario Institute for Cancer Research, Toronto, ON, Canada; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Korah R; Department of Surgery, Yale University, New Haven, CT, USA.
  • Carling T; Department of Surgery, Yale University, New Haven, CT, USA.
  • Agrawal N; Department of Otolaryngology - Head and Neck Surgery, University of Chicago, Chicago, IL, USA.
  • Cipriani N; Department of Pathology, University of Chicago, Chicago, IL, USA.
  • Ball D; Division of Endocrinology, Department of Medicine, Johns Hopkins University, Baltimore, MD, USA.
  • Nelkin B; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA.
  • Rooper LM; Division of Pathology, Johns Hopkins University, Baltimore, MD, USA.
  • Bishop JA; Department of Pathology, University of Texas Southwestern, Dallas, TX, USA.
  • Garnis C; BC Cancer Agency, Vancouver, BC, Canada.
  • Berean K; BC Cancer Agency, Vancouver, BC, Canada.
  • Nicolson NG; Department of Surgery, Yale University, New Haven, CT, USA.
  • Weinberger P; Department of Otolaryngology - Head and Neck Surgery, Louisiana State University Health Sciences Center, Shreveport, LA, USA; Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, USA.
  • Henderson YC; Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lalansingh CM; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Tian M; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Yamaguchi TN; Ontario Institute for Cancer Research, Toronto, ON, Canada; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Livingstone J; Ontario Institute for Cancer Research, Toronto, ON, Canada; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.
  • Salcedo A; Ontario Institute for Cancer Research, Toronto, ON, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada; Department of Human Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
  • Patel K; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Vizeacoumar F; Cancer Research Cluster, University of Saskatchewan, Saskatoon, SK, Canada.
  • Datti A; Network Biology Collaborative Centre, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada; Department of Agricultural, Food, and Environmental Sciences, University of Perugia, Perugia, Italy.
  • Xi L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Nikiforov YE; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Smallridge R; Division of Endocrinology, Department of Medicine, Mayo Clinic, Jacksonville, FL, USA.
  • Copland JA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
  • Marlow LA; Department of Cancer Biology, Mayo Clinic, Jacksonville, FL, USA.
  • Hyrcza MD; Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
  • Delbridge L; Department of Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NWS, Australia.
  • Sidhu S; Department of Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NWS, Australia.
  • Sywak M; Department of Surgery, Royal North Shore Hospital, Sydney, NSW, Australia; University of Sydney, Sydney, NWS, Australia.
  • Robinson B; University of Sydney, Sydney, NWS, Australia; Department of Endocrinology, Royal North Shore Hospital, Sydney, NSW, Australia.
  • Fung K; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada; Department of Oncology, Western University, London, ON, Canada.
  • Ghasemi F; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada.
  • Kwan K; Department of Pathology, Western University, London, ON, Canada.
  • MacNeil SD; Department of Otolaryngology - Head and Neck Surgery, Western University, London, ON, Canada; Department of Oncology, Western University, London, ON, Canada.
Cell Rep ; 43(3): 113826, 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38412093
ABSTRACT
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions of thyroid cancer, including 213 from patients with primary anaplastic thyroid carcinomas. We also whole genome sequenced 9 patients using multi-region sequencing of both differentiated and anaplastic thyroid cancer components. Using these data, we demonstrate thatanaplastic thyroid carcinomas have a higher burden of mutations than other thyroid cancers, with distinct mutational signatures and molecular subtypes. Further, different cancer driver genes are mutated in anaplastic and differentiated thyroid carcinomas, even those arising in a single patient. Finally, we unambiguously demonstrate that anaplastic thyroid carcinomas share a genomic origin with co-occurring differentiated carcinomas and emerge from a common malignant field through acquisition of characteristic clonal driver mutations.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma / Carcinoma Anaplásico da Tireoide Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Glândula Tireoide / Adenocarcinoma / Carcinoma Anaplásico da Tireoide Limite: Humans Idioma: En Revista: Cell Rep Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Canadá País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA